MIRA™ - Principles

---

> Product
> RUTH

---

Clinical Studies

---

Intellectual Property

---

RUTH - Product Description

RUTH is a game-changing device for the detection of breast cancer. Based on MIRA™ (3D functional Metabolic Imaging & Risk Assessment) technology, RUTH offers a comprehensive solution to unmet challenges in breast cancer detection.

MIRA™ is a revolutionary technology, based on proprietary signal acquisition method and advanced processing algorithms, enabling functional quantitative analysis of 3D and infra-red signals emitted from cancerous, benign or normal physiological processes.

Product Features

• Image Acquisition system
  • Generation of a MIRA™ Model(3D functional Metabolic Imaging & Risk Assessment) of a patient's breast
  • Dual 'optic head' for simultaneous panoramic view of patient's breasts and axillary tails
  • Ergonomic design of patient environment and operator console
  
  
• Radiologist's workstation
  • Exam results - Non subjective presentation of findings
  • Further investigation module - Processed material supporting exam result for further investigation and consideration

Product Benefits

• Sensitive and specific diagnosis - Malignant tumors detected and unnecessary biopsies prevented
• Early detection
• Suitable for women of any age
• Safe - Radiation and complication free
• Painless - No manipulation or contact with the breast
• Friendly - Quick procedure with quick results

Procedure

The entire procedure takes only a few minutes and the results are available for further examination by the physician.

---

RUTH - Not available for sale in the US